159 related articles for article (PubMed ID: 18973678)
1. Serological survey on immunity status against polioviruses in children and adolescents living in a border region, Apulia (Southern Italy).
Tafuri S; Prato R; Martinelli D; Calvario A; Bozzi A; Labianca M; Patti A; Lopalco PL; Germinario C
BMC Infect Dis; 2008 Oct; 8():150. PubMed ID: 18973678
[TBL] [Abstract][Full Text] [Related]
2. Sequential inactivated (IPV) and live oral (OPV) poliovirus vaccines for preventing poliomyelitis.
Ciapponi A; Bardach A; Rey Ares L; Glujovsky D; Cafferata ML; Cesaroni S; Bhatti A
Cochrane Database Syst Rev; 2019 Dec; 12(12):CD011260. PubMed ID: 31801180
[TBL] [Abstract][Full Text] [Related]
3. Surveillance of immunity acquired from poliovirus immunization including vaccination with the Sabin strain-derived inactivated vaccine.
Hotta C; Ogawa T; Shirasawa H
Hum Vaccin Immunother; 2019; 15(5):1154-1159. PubMed ID: 30676843
[TBL] [Abstract][Full Text] [Related]
4. Inactivated poliovirus vaccine given alone or in a sequential schedule with bivalent oral poliovirus vaccine in Chilean infants: a randomised, controlled, open-label, phase 4, non-inferiority study.
O'Ryan M; Bandyopadhyay AS; Villena R; Espinoza M; Novoa J; Weldon WC; Oberste MS; Self S; Borate BR; Asturias EJ; Clemens R; Orenstein W; Jimeno J; Rüttimann R; Costa Clemens SA;
Lancet Infect Dis; 2015 Nov; 15(11):1273-82. PubMed ID: 26318714
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity of poliovirus vaccines in chronically malnourished infants: a randomized controlled trial in Pakistan.
Saleem AF; Mach O; Quadri F; Khan A; Bhatti Z; Rehman NU; Zaidi S; Weldon WC; Oberste SM; Salama M; Sutter RW; Zaidi AK
Vaccine; 2015 Jun; 33(24):2757-63. PubMed ID: 25917673
[TBL] [Abstract][Full Text] [Related]
6. Immunity status of adults and children against poliomyelitis virus type 1 strains CHAT and Sabin (LSc-2ab) in Germany.
Eggers M; Terletskaia-Ladwig E; Rabenau HF; Doerr HW; Diedrich S; Enders G; Enders M
BMC Infect Dis; 2010 Dec; 10():347. PubMed ID: 21143885
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity of a supplemental dose of oral versus inactivated poliovirus vaccine.
Moriniere BJ; van Loon FP; Rhodes PH; Klein-Zabban ML; Frank-Senat B; Herrington JE; Pallansch MA; Patriarca PA
Lancet; 1993 Jun; 341(8860):1545-50. PubMed ID: 8099637
[TBL] [Abstract][Full Text] [Related]
8. High level of immunity against poliomyelitis in Albanian refugees in southern Italy.
Lopalco PL; Germinario C; Calvario A; Chironna M; Quarto M; Barbuti S
J Travel Med; 2000; 7(3):111-5. PubMed ID: 11179938
[TBL] [Abstract][Full Text] [Related]
9. Immunogenicity of a new routine vaccination schedule for global poliomyelitis prevention: an open-label, randomised controlled trial.
Sutter RW; Bahl S; Deshpande JM; Verma H; Ahmad M; Venugopal P; Rao JV; Agarkhedkar S; Lalwani SK; Kunwar A; Sethi R; Takane M; Mohanty L; Chatterjee A; John TJ; Jafari H; Aylward RB
Lancet; 2015 Dec; 386(10011):2413-21. PubMed ID: 26388534
[TBL] [Abstract][Full Text] [Related]
10. Anomalous observations on IPV and OPV vaccination.
John TJ
Dev Biol (Basel); 2001; 105():197-208. PubMed ID: 11763328
[TBL] [Abstract][Full Text] [Related]
11. Neutralizing anti-polio antibody titre in newborn babies in post-polio eradication period in Nigeria.
Ughasoro MD; Nnakenyi I; Echendu N; Akpeh JO; Oji-Onuoha S; Anyaoha U; Mbanefo N; Ofodile K
Vaccine; 2023 Nov; 41(46):6820-6823. PubMed ID: 37806806
[TBL] [Abstract][Full Text] [Related]
12. Immune response to an intercalated enhanced inactivated polio vaccine/oral polio vaccine programme in Israel: impact on the control of poliomyelitis.
Swartz TA; Handsher R; Manor Y; Stoeckel P; Barkay A; Mendelson E; Leventhal A
Vaccine; 1998 Dec; 16(20):2090-5. PubMed ID: 9796069
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of supplemental doses of poliovirus vaccine for children aged 6-9 months in Moradabad, India: a community-based, randomised controlled trial.
Estívariz CF; Jafari H; Sutter RW; John TJ; Jain V; Agarwal A; Verma H; Pallansch MA; Singh AP; Guirguis S; Awale J; Burton A; Bahl S; Chatterjee A; Aylward RB
Lancet Infect Dis; 2012 Feb; 12(2):128-35. PubMed ID: 22071249
[TBL] [Abstract][Full Text] [Related]
14. Humoral and mucosal immunity in infants induced by three sequential inactivated poliovirus vaccine-live attenuated oral poliovirus vaccine immunization schedules. Baltimore Area Polio Vaccine Study Group.
Modlin JF; Halsey NA; Thoms ML; Meschievitz CK; Patriarca PA
J Infect Dis; 1997 Feb; 175 Suppl 1():S228-34. PubMed ID: 9203721
[TBL] [Abstract][Full Text] [Related]
15. Poliomyelitis prevention in the United States: introduction of a sequential vaccination schedule of inactivated poliovirus vaccine followed by oral poliovirus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR Recomm Rep; 1997 Jan; 46(RR-3):1-25. PubMed ID: 9026708
[TBL] [Abstract][Full Text] [Related]
16. Lower immunity to poliomyelitis viruses in Australian young adults not eligible for inactivated polio vaccine.
Hendry AJ; Beard FH; Dey A; Quinn H; Hueston L; Dwyer DE; McIntyre PB
Vaccine; 2020 Mar; 38(11):2572-2577. PubMed ID: 32037225
[TBL] [Abstract][Full Text] [Related]
17. Successful control of poliomyelitis by a combined OPV/IPV polio vaccine program in the West Bank and Gaza, 1978-93.
Tulchinsky T; Abed Y; Handsher R; Toubassi N; Acker C; Melnick J
Isr J Med Sci; 1994; 30(5-6):489-94. PubMed ID: 8034509
[TBL] [Abstract][Full Text] [Related]
18. Randomized trial of inactivated and live polio vaccine schedules in Guatemalan infants.
Asturias EJ; Dueger EL; Omer SB; Melville A; Nates SV; Laassri M; Chumakov K; Halsey NA
J Infect Dis; 2007 Sep; 196(5):692-8. PubMed ID: 17674310
[TBL] [Abstract][Full Text] [Related]
19. Seroprevalence of Poliomyelitis Antibodies Among Children Aged 1 to 4 Years Old and Factors Associated With Poliovirus Susceptibility; Mexican Health and Nutrition Survey, 2012.
Díaz-Quiñónez JA; Díaz-Ortega JL; Cruz-Hervert P; Ferreira-Guerrero E; Delgado-Sánchez G; Ferreyra-Reyes L; López-Martínez I; Torres-Longoria B; Aparicio-Antonio R; Montero-Campos R; Mongua-Rodríguez N; Garcia-Garcia L
Clin Infect Dis; 2018 Oct; 67(suppl_1):S110-S114. PubMed ID: 30376082
[TBL] [Abstract][Full Text] [Related]
20. [Effectiveness of different strategies of vaccine prophylaxis for poliomyelitis in the Ukraine].
Moĭseieva HV; Zadorozhna VI
Lik Sprava; 2002; (2):85-8. PubMed ID: 12073271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
